Allscripts (MDRX) Tops Q2 EPS by 1c, Affirms FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Allscripts Announces Second Quarter 2015 Results
August 4, 2015 4:01 PM EDTRecord second-quarter bookings of $260 million, 11 percent year-over-year growth Revenue totals $352 million, recurring revenue grows 8 percent year-over-year Adjusted EBITDA of $62 million, 17 percent year-over-year growth
CHICAGO, Aug. 4, 2015 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) (Allscripts) announced its financial results for the three and six months ended June 30, 2015.
Second-Quarter and Six-Month Bookings Highlights:
Bookings(1) were $260 million, a second-quarter record, compared with $233 million in the second quarter of 2014, an 11 percent increase. A higher mix of... More
